Literature DB >> 8279329

MR findings after depth electrode implantation for medically refractory epilepsy.

M A Merriam1, R A Bronen, D D Spencer, G McCarthy.   

Abstract

PURPOSE: To evaluate using MR imaging chronic changes in the brain parenchyma after electroencephalography depth electrode placement in patients with medically refractory epilepsy.
METHODS: A retrospective review of MR scans in 57 patients who underwent stereotactic placement of 210 depth electrodes was performed. Scans were evaluated for evidence of gliosis, hemorrhage, or infection along the probe tracts.
RESULTS: Signal abnormalities along the probe tracts were seen in 38 patients (67%). Of the 210 probe tracts evaluated on long-repetition-time images, 85 (41%) were associated with punctate hyperintensity and four (2%) with punctate hypointensity; 120 (57%) showed no MR changes to suggest prior electrode placement. One probe placement was complicated by a significant intraparenchymal hemorrhage.
CONCLUSIONS: Depth electrode implantation for electroencephalography monitoring results in imperceptible or minimal chronic changes as detected by MR in almost all patients. The punctate hypersensitivity on long-repetition-time images is though to be caused by gliosis along the probe tracts. These signal changes should not be confused with the seizure focus. Significant hemorrhage or infection is a rare complication of probe placement. Incorporation of MR angiographic data with conventional spin-echo images at the time of stereotactic probe placement may further reduce the low incidence of probe-related hemorrhage.

Entities:  

Mesh:

Year:  1993        PMID: 8279329

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  2 in total

Review 1.  Stereoelectroencephalography: Indication and Efficacy.

Authors:  Koji Iida; Hiroshi Otsubo
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-06-20       Impact factor: 1.742

Review 2.  Imaging of Neuromodulation and Surgical Interventions for Epilepsy.

Authors:  M E Adin; D D Spencer; E Damisah; A Herlopian; J L Gerrard; R A Bronen
Journal:  AJNR Am J Neuroradiol       Date:  2021-08-05       Impact factor: 4.966

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.